Download

334 views
255 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
334
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Download

  1. 1. Jeff Kozloff President, Verilogue 500 Office Center Drive, Suite 400 Ft. Washington, PA 19034 267-513-1722 [email_address] www.verilogue.com
  2. 2. Verilogue captures physician and patient information at the point-of-practice TM Verilogue provides digital recording devices to physicians so they can record their conversations with a few patients each month* *Patients opt-into the research and sign a HIPAA authorization release
  3. 3. Verilogue was created as a response to the pharmaceutical industry’s need for more accurate and actionable customer information <ul><li>Trend towards more personalized, targeting patient-centric medicine </li></ul><ul><li>Frustration with lack of access to data that matters most </li></ul><ul><li>Patent-pending customer analytics system - Tech Startup Company of the Year </li></ul><ul><li>Rapidly growing proprietary database </li></ul><ul><li>Proven sales model within and across top-tier pharmaceutical customers </li></ul><ul><li>Building world-class team & partnerships </li></ul>- - Company History - - Why <ul><li>Incorporated as Delaware LLC in 2Q 2006 </li></ul><ul><li>Began capturing data & selling to clients in 4Q 2006 </li></ul><ul><li>Closed $4MM Series A financing with Edison in Dec 2007 ( C-corp ) </li></ul>When How
  4. 4. Verilogue’s management team has experience creating and selling marketing services to the pharmaceutical industry Verilogue Mgmt Team <ul><li>Deep buyer & supplier experience in pharmaceutical industry </li></ul><ul><li>Successfully created and sold research products to pharmaceutical companies in previous jobs </li></ul><ul><li>Previous startup & product commercialization experience </li></ul><ul><li>President is co-author of US Patent </li></ul><ul><li>Strong academic backgrounds & relationships </li></ul><ul><li>Attractive strategic partnerships </li></ul><ul><li>Jeff Kozloff, President </li></ul><ul><li>Jamison Barnett, Vice President Operations & Analytics </li></ul><ul><li>Larry Novacich, Vice President Sales & Client Services </li></ul><ul><li>Ryan Orr, Managing Director Information Technology </li></ul>
  5. 5. What is the value proposition? Verilogue’s patent-pending data collection and customer analytics system turns dialogue into data TM <ul><li>Captures nationwide data in real-time </li></ul><ul><li>Sampling from customer’s natural environment </li></ul><ul><li>Computational linguistic analysis derives new, actionable customer insights </li></ul><ul><li>Proprietary normative database </li></ul><ul><li>Customer voice is universal </li></ul><ul><li>Proprietary insights reveal new drivers of customer behavior </li></ul><ul><li>Enriches the development and effectiveness of marketing strategies and tactics </li></ul><ul><li>Improve ROI </li></ul>Customer benefit Verilogue turnkey analytics system
  6. 6. What is the market opportunity? The physician-patient dialogue is the epicenter of the HC continuum Physicians PATIENTS Government Agencies Hospitals Other Regulatory Bodies Caregivers Life Science Companies Managed Care / Insurers Nurses
  7. 7. What is the growth potential? Numerous vertical, horizontal and global expansion opportunities Domestic Pharma & CRO opportunity Time Global Pharma & CRO opportunity Healthcare Social Network & Global Business Intelligence Engine Multi-channel Social Network & Global Business Intelligence Engine $30MM+ $60MM+ $100MM+ $500MM+ Current Growth Phase
  8. 8. Edison Venture Fund is the ideal partner for Verilogue WHY EDISON VENTURE FUND? <ul><li>Growth and expansion capital in one-round </li></ul><ul><li>Leading VC with deep domain expertise </li></ul><ul><li>SaaS experience, with impressive existing portfolio and multiple successful Pharma IT exits </li></ul><ul><li>Reputation & recommendations </li></ul><ul><li>Commercialization philosophy & enthusiasm </li></ul><ul><li>Use of funds </li></ul><ul><li>Time to close </li></ul>Verilogue Funding Requirements & Criteria
  9. 9. John Martinson Director, Verilogue Managing Partner, Edison Venture Fund PWC Money Tree February 5, 2008
  10. 10. Verilogue’s Attractiveness for Edison <ul><li>Fit Edison’s profile, except early stage </li></ul><ul><li>Founders and management experienced in software and services for drug industry </li></ul><ul><li>Unique solution for pharma brand manager </li></ul><ul><li>Market Research is growth segment </li></ul><ul><li>Penetrated major drug companies </li></ul><ul><li>Account expansion potential confirmed </li></ul><ul><li>Gross margins boosted by reusing information </li></ul><ul><li>Capital efficient, scalable business model </li></ul><ul><li>Management driven for success </li></ul>
  11. 11. Edison Value-Added Services <ul><li>2 BOD seats </li></ul><ul><ul><li>John Martinson works with 7 Pharma IT companies </li></ul></ul><ul><ul><li>Heather Torak, COO Cadient, Edison Director Network </li></ul></ul><ul><ul><li>Orlando Mendoza, Director Analysis, BOD Observer </li></ul></ul><ul><li>Risks and opportunities identified by due diligence </li></ul><ul><li>180 day plan to address key concerns </li></ul><ul><li>Strategic guidance and business priorities </li></ul><ul><li>Management referrals </li></ul><ul><li>Bank referrals </li></ul><ul><li>Service provider referrals </li></ul><ul><li>Pharma IT portfolio companies share best practices and contacts </li></ul>
  12. 12. Virginia > 703-903-9546 - Gary Golding, General Partner [email_address] - Sever Totia – Principal [email_address] - Lenard Marcus, Investment Mgr. [email_address] A local presence throughout the region Get to Know Edison Better <ul><ul><li>Visit our website: </li></ul></ul><ul><li> www.edisonventure.com </li></ul><ul><li>- Portfolio details and personnel bios - Info. section for service providers </li></ul><ul><li>Subscribe to the eLuminator - Monthly current events e-newsletter </li></ul>Pennsylvania > 609-873-9212 - Doug Petillo, Partner [email_address] - Michael Kopelman, Principal [email_address] New Jersey/NY > 609-896-1900 - Joe Allegra, General Partner [email_address] - Chris Sugden, General Partner [email_address] - Ryan Ziegler, Investment Manager [email_address] - John Martinson, Managing Partner [email_address] - Ross Martinson, General Partner [email_address] Call our point person: Tim Foster Business Development Manager Edison Venture Fund 609-873-9227 or 609-712-1562 [email_address]

×